Eagle Pharmaceuticals
(NASDAQ:EGRX)
$35.48
At close: Dec 1(Delayed 15-Minutes)
Get Real Time Here
$35.48
PreMarket: 4:01PM EDT
Day Range- - -52 Wk Range24.35 - 56.43Open / Close- / -Float / Outstanding7M / 13M
Vol / Avg.- / 170.4KMkt Cap461.8MP/E21.6350d Avg. Price31.67
Div / Yield-Payout Ratio-Total Float7MEPS-0.54

Eagle Pharmaceuticals Stock (NASDAQ:EGRX), Quotes and News Summary

Eagle Pharmaceuticals Stock (NASDAQ: EGRX) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range24.35 - 56.43Open / Close- / -Float / Outstanding7M / 13M
Vol / Avg.- / 170.4KMkt Cap461.8MP/E21.6350d Avg. Price31.67
Div / Yield-Payout Ratio-Total Float7MEPS-0.54
Seeking Alpha - Nov 7, 2022, 1:16PM
Seeking Alpha - Nov 4, 2022, 1:25PM
Seeking Alpha - Aug 8, 2022, 1:50PM
Seeking Alpha - May 10, 2022, 3:45PM
Seeking Alpha - Mar 7, 2022, 10:51AM
Seeking Alpha - Mar 4, 2022, 12:10PM
Seeking Alpha - Dec 15, 2021, 2:06PM
Sector: Health Care.Industry: Biotechnology
Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS0.9101.120 0.2100
REV62.080M65.901M3.821M
Q2 2022Est.ActualSurprise
EPS3.3601.560 -1.8000
REV116.890M74.136M-42.754M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Eagle Pharmaceuticals (EGRX) stock?

A

You can purchase shares of Eagle Pharmaceuticals (NASDAQ: EGRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Eagle Pharmaceuticals's (EGRX) competitors?

Q

What is the target price for Eagle Pharmaceuticals (EGRX) stock?

A

The latest price target for Eagle Pharmaceuticals (NASDAQ: EGRX) was reported by Cantor Fitzgerald on Monday, March 2, 2020. The analyst firm set a price target for 46.00 expecting EGRX to rise to within 12 months (a possible 29.65% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Eagle Pharmaceuticals (EGRX)?

A

The stock price for Eagle Pharmaceuticals (NASDAQ: EGRX) is $35.48 last updated December 1, 2022, 9:00 PM UTC.

Q

Does Eagle Pharmaceuticals (EGRX) pay a dividend?

A

There are no upcoming dividends for Eagle Pharmaceuticals.

Q

When is Eagle Pharmaceuticals (NASDAQ:EGRX) reporting earnings?

A

Eagle Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 7, 2022.

Q

Is Eagle Pharmaceuticals (EGRX) going to split?

A

There is no upcoming split for Eagle Pharmaceuticals.

Q

What sector and industry does Eagle Pharmaceuticals (EGRX) operate in?

A

Eagle Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.